Literature DB >> 12765948

Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity.

Hans J Woerle1, Christian Meyer, Emilia M Popa, Philip E Cryer, John E Gerich.   

Abstract

During liver transplantation and after both meal ingestion and prolonged fasting, renal glucose release (RGR) increases while hepatic glucose release (HGR) decreases. These and other observations have led to the concept of hepatorenal reciprocity. According to this concept, reciprocal changes in hepatic and renal glucose release may occur to minimize deviations from normal glucose homeostasis. We further assessed this concept by testing the hypothesis that during counterregulation of hypoglycemia in patients with type 2 diabetes, who would be expected to have reduced HGR, RGR would be increased. Accordingly, we performed hypoglycemic hyperinsulinemic clamp experiments (approximately 3.1 mmol/l) in 12 type 2 diabetic and in 10 age-weight-matched nondiabetic volunteers and measured total endogenous glucose release (TEGR) and RGR using a combined isotopic net balance approach. HGR was calculated as the difference between TEGR and RGR since only these organs are capable of releasing glucose. We found that during comparable hypoglycemia and hyperinsulinemia, TEGR was reduced in type 2 diabetes (6.6 +/- 0.6 vs. 10.2 +/- 1.1 micromol. kg(-1). min(-1) in nondiabetic volunteers, P = 0.01) due to reduced HGR (3.9 +/- 0.5 vs. 8.6 +/- 1.0 micromol. kg(-1). min(-1) in nondiabetic volunteers, P = 0.0015). In contrast, RGR was increased approximately twofold in type 2 diabetes (3.3 +/- 0.5 vs. 1.6 +/- 0.3 micromol. kg(-1). min(-1) in nondiabetic volunteers, P = 0.015). Plasma epinephrine, lactate, and free fatty acid concentrations, which would promote RGR, were also greater in type 2 diabetes (all P < 0.01). Our results provide further support for hepatorenal reciprocity and may explain at least in part the relatively low occurrence of severe hypoglycemia in type 2 diabetes compared with type 1 diabetes where both HGR and RGR counterregulatory responses are reduced.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765948     DOI: 10.2337/diabetes.52.6.1386

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy?

Authors:  Rong Huang; Jing Zhu; Lin Zhang; Xiaolin Hua; Weiping Ye; Chang Chen; Kun Sun; Weiye Wang; Liping Feng; Jun Zhang
Journal:  Pregnancy Hypertens       Date:  2019-06-27       Impact factor: 2.899

2.  Severe hypoglycemia in a nondiabetic patient leading to acute respiratory failure.

Authors:  Muhammad Ahsan Baig; Shaukat Ali; Javeria Rasheed; Michael Bergman; Vladimir Privman
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 3.  Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation.

Authors:  Chul Soo Park
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 4.  Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Authors:  Giuseppe Pugliese; Giuseppe Penno; Andrea Natali; Federica Barutta; Salvatore Di Paolo; Gianpaolo Reboldi; Loreto Gesualdo; Luca De Nicola
Journal:  J Nephrol       Date:  2020-02       Impact factor: 3.902

Review 5.  Hypoglycemia in Patients with Diabetes and Renal Disease.

Authors:  Mazen Alsahli; John E Gerich
Journal:  J Clin Med       Date:  2015-05-13       Impact factor: 4.241

Review 6.  Dietary Flavonoids in the Prevention of T2D: An Overview.

Authors:  Hana Alkhalidy; Yao Wang; Dongmin Liu
Journal:  Nutrients       Date:  2018-03-31       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.